Fig. 3From: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editingDiagram of the different types of existing gene editing tools: engineered meganucleases, zinc-finger nucleases (ZFNs), TAL effector nucleases (TALENs), and CRISPR/Cas9 nucleasesBack to article page